41
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis

, , , , &
Pages 499-504 | Published online: 18 Jul 2013

References

  • Adam, R. D. (1991). The biology of Giardia spp. Microbiological Reviews, 55,706–732.
  • Al-Waili, N. S., Al-Waili, B. H. & Saloom, K. Y. (1988). Therapeutic use of mebendazole in giardial infections. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 438.
  • Arencibia, A. A., Escobedo, A. A., Nfifiez, F. A. & Almirall, P. (2001). Pardsitos intestinales en nifios que asisten a una escuela primaria urbana de Ciudad de la Habana. Boletin Epidemiológico del Instituto Pedro Kour, 11, 58–59.
  • Armitage, P. & Berry, G. (1987). Statistical Methods in Medical Research, 2nd Edn. Oxford: Blackwell Scientific.
  • Cedillo-Rivera, R. & Mufioz, O. (1992). In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. Journal of Medical Microbiology, 37, 221-224.
  • Chavez, B., Cedillo-Rivera, R. & Martinez-Palomo, A. (1992). Giardia lamblia: ultrastructural study of the in vitro effect of benzimidazoles. Journal of Protozoology, 39, 510–515.
  • Cimerman, B., Coura, L. C., Salles, J. M. C., Gurvitz, R., Rocha, R. S., Bandeira, S., Cimerman, S. & Katz, N. (1997). Evaluation of secnidazole gel and tinidazole suspension in the treat-ment of giardiasis in children. Brazilian Journal of Infectious Diseases, 1, 241–247.
  • De Silva, N., Guyatt, H. & Bundy, D. (1997). Anthelmintics: a comparative review of their clinical pharmacology. Drugs, 53,769–788.
  • Di Martino, L., Nocerino, A. & Mantovani, M. P. (1991). Mebendazole in giardial infections: con-firmation of failure of treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 85, 557–558.
  • Di Prisco, M. C., Jimenez, J. C., Rodriguez, N., Costa, V., Villamizar, J., Silvera, A., Carrillo, M., Lira, C., Zerpa, E. & Lopez, Y. (2000). Clinical trial with secnidazole in single dose in Venezuelan children infected by Giardia intestinalis. Investigación Clinica, 41, 179–188.
  • Edlind, T. D., Hang, T. L. & Chakraborty, P. R. (1990). Activity of the anthelmintic benzimidazoles against Giardia intestinalis in vitro. Journal of Infectious Diseases, 162, 1408–1411.
  • Escobedo, A. A., Nfifiez, F. A., Moreira, I., Vega, E., Pareja, A. & Almirall, P. (2003). Comparison of chloroquine, albendazole and tinidazole in the treat-ment of children with giardiasis. (2003). Annals of Tropical Medicine and Parasitology, 97, 367–371.
  • Gascon, J., Moreno, A., Valls, M. R., Miro, J. M. & Corachan, M. (1989). Failure of mebendazole treat-ment in Giardia lamblia infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 647.
  • Hall, A. & Nahar, Q. (1993). Albendazole as a treat-ment for infections with Giardia intestinalis in children in Bangladesh. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87,84–86.
  • Harris, J. C., Plummer, S. & Lloyd, D. (2001). Anti-giardial drugs. Applied Microbiology and Biotechnology, 57,614–619.
  • Hutchison, J. G., Johnson, M. N., Plevey, M. V., Thangkhiew, I. & Aldney, C. (1975). Clinical trial of mebendazole, a broad-spectrum anthelminthic. British Medical Journal, ii, 309–310.
  • Jokipii, A. M. M. & Jokipii, L. (1977). The prepatency of Giardia. Lancet, 1, 1095–1097.
  • Katelaris, P. H., Naeem, A. & Farthing, M. J. (1994). Activity of metronidazole, azithromycin and three benzimidazoles on Giardia lamblia growth and attach-ment to a human intestinal cell line. Alimentary Pharmacology and Therapeutics, 8, 187–192.
  • Katiyar, S. K., Gordon, V. R., McLaughlin, G. L. & Edlind, T. D. (1994). Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrobial Agents and Chemotherapy, 38, 2086–2090.
  • Ortega, Y. R. & Adam, R. D. (1997). Giardia: overview and update. Clinical Infectious Diseases, 25,545–550.
  • Lengerich, E. J., Addiss, D. G. & Juraneck, D. D. (1994). Severe giardiasis in the United States. Clinical Infectious Diseases, 18, 760–763.
  • Majewska, A. C., Kasprzak, W., de Jonckheere, J. F. & Kaczmarek, E. (1991). Heterogeneity in the sensitivity of stocks and clones of Giardia to metronidazole and ornidazole. Transactions of the Royal Society of Tropical Medicine and Hygiene, 85, 67–69.
  • Morgan, U. M., Reynoldson, J. A. & Thompson, R. C. (1993). Activities of several benzimidazoles and tubulin inhibitors against Giardia spp. in vitro. Antimicrobial Agents and Chemotherapy, 37, 328–331.
  • Nash, T. E., ON, C. A., Thomas, E., Subramanian, G., Keiser, P. & Moore, T. A. (2001). Treatment of patients with refractory giardiasis. Clinical Infectious Diseases, 33, 22–28.
  • Núñez, F. A., Hernández, M. & Finlay, C. M. (1999). Longitudinal study of giardiasis in three day care centres of Havana City. Acta Tropica, 73, 237–242.
  • Rousham, E. K. (1994). An increase in Giardia duodenalis infection among children receiving periodic anthelmintic treatment in Bangladesh. Journal of Tropical Pediatrics, 40, 329–333.
  • Sadjjadi, S. M., Alborzi, A. W. & Mostovfi, H. (2001). Comparative clinical trial of mebendazole and metronidazole in giardiasis of children. Journal of Tropical Pediatrics, 47, 176–178.
  • Uperoft, J. A. & Uperoft, P. (1994). Two distinct varieties of Giardia in a mixed infection from a single human patient. Journal of Eukaryotic Microbiology, 41, 189–194.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.